Phreesia(NYSE) PHR

Phreesia helps patients check in for doctor visits digitally. It makes paying medical bills easier for patients and doctor offices. The software also helps doctors manage schedules and patient health records.

Digital Tools for Modern Doctors

• Subscription and Services: Revenue from software access, insurance verification tools, and hardware leasing; reached $52.7 million for the three months ended July 31, 2026.
• Payment Solutions: Fees from processing patient medical payments and financing fees on cardholder receivables; totaled $38.5 million for the three months ended July 31, 2026.
• Network Solutions: Targeted health communications and education programs for patients on behalf of life sciences companies; amounted to $38.3 million for the three months ended July 31, 2026.

Strategic Growth and Cost Savings

• Acquired AccessOne Parent Holdings, Inc. on Nov. 12, 2025, to expand patient financing and payment options.
• Launched a restructuring plan on May 7, 2026, to eliminate approximately 220 positions and reduce operating expenses.
• Refinanced existing debt on March 13, 2026, by securing a new credit facility for up to $275 million.
• Integrated artificial intelligence into the platform to improve patient scheduling and clinical intake workflows.

A Better Way to Check In

Phreesia is embedded in the daily workflows of healthcare providers, facilitating one in six ambulatory visits in the United States during fiscal 2026. The platform uses automated tools to gather clinical data and patient-reported outcomes across approximately 25 medical specialties.

Tracking Revenue and Client Growth

• Total revenue was $129.5 million for the three months ended July 31, 2026, up 10% year over year.
• Net income reached $1.9 million for the three-month period ended July 31, 2026, compared to $0.7 million in the prior year.
• Average number of healthcare services clients grew to 4,744 for the three months ended July 31, 2026, up from 4,467 year over year.
• Free cash flow hit $13.8 million for the three months ended July 31, 2026, up from $9.6 million in the same period last year.
• P/E ratio, which measures stock price relative to earnings, was 86.5 for the period ended July 31, 2026, down 85.9% year over year.

Phreesia’s Path Forward

Phreesia has transitioned from a digital check-in tool to a comprehensive platform covering patient access, payments, and clinical outcomes. Recent acquisitions and cost-alignment efforts reflect a focus on integrating financial services with administrative healthcare software.